Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Operating Expenses | 5,110 | 4,010 | 2,180 | 2,280 | 1,260 |
| Operating Income | -5,110 | -4,010 | -2,180 | -2,280 | -1,260 |
| Other Income | 1,240 | 1,510 | 1,600 | 1,970 | 100 |
| Pre-tax Income | -3,870 | -2,500 | -580 | -310 | -1,160 |
| Income Tax | 0 | 0 | 0 | 10 | 0 |
| Net Income Continuous | -3,877 | -2,507 | -584 | -319 | -1,164 |
| Net Income Discontinuous | 0 | 0 | 0 | 140 | 0 |
| Net Income | $-3,877 | $-2,507 | $-584 | $-180 | $-1,164 |
| EPS Basic Total Ops | -4.18 | -2.73 | -0.64 | -0.16 | -1.61 |
| EPS Basic Continuous Ops | -4.25 | -2.75 | -0.64 | -0.35 | -1.67 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.15 | N/A |
| EPS Diluted Total Ops | -4.18 | -2.73 | -0.64 | -0.16 | -1.61 |
| EPS Diluted Continuous Ops | -4.06 | -2.61 | -0.61 | -0.33 | -1.55 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.15 | N/A |
| EBITDA(a) | $-4,900 | $-3,900 | $-2,130 | $-2,240 | $-1,250 |